Filipy R E, Kathren R L
U.S. Transuranium and Uranium Registries, Washington State University, Richland, WA 99352, USA.
Health Phys. 1996 Feb;70(2):153-9. doi: 10.1097/00004032-199602000-00001.
Concentrations of 239 + 240Pu and 241Am in human soft tissues (testes, thyroid gland, kidneys, spleen, heart, skeletal muscle, brain, and pancreas) were compared to those in livers of the same subjects. The subjects were volunteer donors with occupational exposures to plutonium and americium autopsied as part of the United States Transuranium and Uranium Registries program. The temporal distributions of tissue-to-liver ratios were compared to liver uptake fractions assumed on the basis of current models to estimate the initial uptake fractions for each tissue studied. Regressions of the ratios were used to compare tissue retention half-times to those of the liver. Effective half-times for plutonium and americium in the tissues studied were similar to those for the liver with three exceptions: (1) the clearance half-time for plutonium in kidneys is shorter than that of liver; (2) the retention half-time for plutonium in testes is longer than that of liver; and (3) the retention half-time for americium in skeletal muscle was longer than in the liver. Next to liver, the greatest initial uptake of systemic actinides was in skeletal muscle and the greatest initial concentrations were in the spleen. The uptake fraction of plutonium in the testes proposed by the ICRP was verified.
将人体软组织(睾丸、甲状腺、肾脏、脾脏、心脏、骨骼肌、大脑和胰腺)中239 + 240钚和241镅的浓度与同一受试者肝脏中的浓度进行了比较。这些受试者是职业性接触钚和镅的志愿捐赠者,作为美国超铀元素和铀登记计划的一部分接受了尸检。将组织与肝脏的比率的时间分布与基于当前模型假设的肝脏摄取分数进行比较,以估计所研究的每个组织的初始摄取分数。用比率的回归分析来比较组织的滞留半衰期与肝脏的滞留半衰期。所研究组织中钚和镅的有效半衰期与肝脏的相似,但有三个例外:(1)肾脏中钚的清除半衰期比肝脏短;(2)睾丸中钚的滞留半衰期比肝脏长;(3)骨骼肌中镅的滞留半衰期比肝脏长。除肝脏外,全身锕系元素的最大初始摄取发生在骨骼肌,最大初始浓度在脾脏。国际辐射防护委员会(ICRP)提出的睾丸中钚的摄取分数得到了验证。